Skip to main content
Clinical Trials/CTRI/2024/07/071294
CTRI/2024/07/071294
Not yet recruiting
Phase 4

Comparison of double-J stenting versus ureteral catheters in percutaneous nephrolithotomy

Not provided1 site in 1 country200 target enrollmentStarted: August 12, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Enrollment
200
Locations
1
Primary Endpoint
To determine if ureteral Catheters have significantly reduced stent related complications when compared with double J stenting

Overview

Brief Summary

This randomised control trial (open label) aims at comparing the placement of uretral catheters in patient post PCNL (intervention) with those in whom double J stents have been placed (the accepted standard). The study primarily aims to determine if the stent related symptoms are significantly less in ureteral catheter arm and secondarily to determine if there is any significant increase in other post operative complications (urinary extravasation, bleeding)

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
12.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients of ages above 12 years undergoing PCNL in department of Urology in IPGMER, KOLKATA.
  • Cumulative stone diameter ≤ 4 cm No ureteral obstruction Up to two access sites Those consented to be part of study.

Exclusion Criteria

  • Patient who did not gave consent for the study Patients below age of 12 years Cumulative stone diameter more than 4 cm Presence of ureteral obstruction More than 2 access sites.

Outcomes

Primary Outcomes

To determine if ureteral Catheters have significantly reduced stent related complications when compared with double J stenting

Time Frame: Day 1 | Day 2 | 2 Weeks

Secondary Outcomes

  • To determine if ureteral catheters have comparable rates of complications for urinary extravasation and need for blood transfusion with double J stents(Day 1)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Suhan Khamar

IPGMER and SSKMH

Study Sites (1)

Loading locations...

Similar Trials